Max Allsworth
Overview
Explore the profile of Max Allsworth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction: High-quality identification of volatile organic compounds (VOCs) originating from breath
Arulvasan W, Chou H, Greenwood J, Ball M, Birch O, Coplowe S, et al.
Metabolomics
. 2025 Jan;
21(1):22.
PMID: 39863829
No abstract available.
2.
Arulvasan W, Greenwood J, Ball M, Chou H, Coplowe S, Birch O, et al.
Metabolomics
. 2025 Jan;
21(1):17.
PMID: 39832034
Introduction: Breath Volatile organic compounds (VOCs) are promising biomarkers for clinical purposes due to their unique properties. Translation of VOC biomarkers into the clinic depends on identification and validation: a...
3.
Taylor A, Blum S, Ball M, Birch O, Chou H, Greenwood J, et al.
Biol Methods Protoc
. 2024 Dec;
9(1):bpae087.
PMID: 39659672
A new pre-clinical method for capturing breath samples from intubated mice is presented. This method significantly reduces background levels, allowing more accurate measurements of VOCs originating from the breath ("on-breath")...
4.
Arulvasan W, Chou H, Greenwood J, Ball M, Birch O, Coplowe S, et al.
Metabolomics
. 2024 Sep;
20(5):102.
PMID: 39242444
Introduction: Volatile organic compounds (VOCs) can arise from underlying metabolism and are detectable in exhaled breath, therefore offer a promising route to non-invasive diagnostics. Robust, precise, and repeatable breath measurement...
5.
Chou H, Godbeer L, Allsworth M, Boyle B, Ball M
Metabolomics
. 2024 Jul;
20(4):72.
PMID: 38977623
Background: The multitude of metabolites generated by physiological processes in the body can serve as valuable biomarkers for many clinical purposes. They can provide a window into relevant metabolic pathways...
6.
John T, Shrestha N, Hasan L, Pappan K, Birch O, Grove D, et al.
J Breath Res
. 2024 Mar;
18(2).
PMID: 38502958
infection (CDI) is the leading cause of hospital-acquired infective diarrhea. Current methods for diagnosing CDI have limitations; enzyme immunoassays for toxin have low sensitivity andpolymerase chain reaction cannot differentiate infection...
7.
Chou H, Arthur K, Shaw E, Schaber C, Boyle B, Allsworth M, et al.
J Breath Res
. 2024 Jan;
18(2).
PMID: 38290132
Exhaustive exercise can induce unique physiological responses in the lungs and other parts of the human body. The volatile organic compounds (VOCs) in exhaled breath are ideal for studying the...
8.
Ferrandino G, Ricciardi F, Murgia A, Banda I, Manhota M, Ahmed Y, et al.
Biomedicines
. 2023 Nov;
11(11).
PMID: 38001958
Cirrhosis detection in primary care relies on low-performing biomarkers. Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with decompensation when causal treatments are less effective at...
9.
Ferrandino G, De Palo G, Murgia A, Birch O, Tawfike A, Smith R, et al.
J Clin Transl Hepatol
. 2023 Mar;
11(3):638-648.
PMID: 36969895
Background And Aims: The prevalence of chronic liver disease in adults exceeds 30% in some countries and there is significant interest in developing tests and treatments to help control disease...
10.
Murgia A, Ahmed Y, Sweeney K, Nicholson-Scott L, Arthur K, Allsworth M, et al.
Biomedicines
. 2021 Nov;
9(11).
PMID: 34829792
The gold standard method for chronic liver diseases diagnosis and staging remains liver biopsy, despite the spread of less invasive surrogate modalities based on imaging and blood biomarkers. Still, more...